# Nd:YAG1064nm laser functions against Sporothrix globosa by inducing PANoptosis via the regulation of ZBP1-induced PANoptosome activation

**Authors:** Tianyi Yan, Jinyan Nan, Rihua Jiang, Feng Chen, Jinran Li

PMC · DOI: 10.3389/fmicb.2025.1555338 · 2025-03-26

## TL;DR

This study shows that a specific laser treatment fights a fungal infection by triggering a complex cell death process involving immune responses.

## Contribution

The study reveals the Nd:YAG1064nm laser induces PANoptosis via ZBP1-PANoptosome activation against Sporothrix globosa.

## Key findings

- ZBP1 expression was significantly increased in patients infected with Sporothrix globosa.
- Laser treatment inhibited fungal growth and induced PANoptosis-related cell death in vitro and in vivo.
- Laser therapy activated immune responses through Th1/Th17 cells and PANoptosome complex activation.

## Abstract

Due to the emergence of drug resistance in recent years, there is a need for new non-pharmacological treatment methods for sporotrichosis. Our previous study demonstrated that the Nd:YAG1064nm laser exhibited remarkable antifungal activity against Sporothrix globosa, but its exact mechanism remains unclear. This study aimed to detect PANoptosis regulatory protein ZBP1 expression in the skin lesions of patients with sporotrichosis, reveal the exact mechanism of Nd:YAG1064nm laser against sporotrichosis, and provide novel targets and methods for the diagnosis, assessment, and treatment of sporotrichosis.

The ZBP1 level of 60 patients with sporotrichosis (≤3 months; n = 30 and >3 months; n = 30) and 30 HC were retrospectively reviewed using immunohistochemistry. The morphological changes, Hoechst/PI apoptosis and necroptosis preliminary exploration analysis, DNA fragmentation, calcium determination, and metacaspase activation were investigated in vitro. For the in vivo studies, mice were infected with S. globosa and then treated with a laser, and their footpad skin lesions and changes in the histology of tissue samples were compared. Changes in the levels of ZBP1, PANoptosome [RIPK1, RIPK3, Fas-associated death domain protein (FADD), CASP8], pyroptosis (CASP1, GSDMD), apoptosis (CASP3), and necroptosis (MLKL) related proteins were assessed using immunohistochemistry, whereas the levels of interleukin 17 (IL-17) and interferon gamma (IFN-γ) in peripheral blood were tested by enzyme-linked immunosorbent assay. ZBP1 expression was significantly increased in S. globosa-infected patients. Laser treatment effectively inhibited the growth of S. globosa in vitro, destroying its morphological structure, and maybe inducing apoptosis and necroptosis. Moreover, DNA fragmentation, calcium release into the cytoplasm, and metacaspase activation were observed. In addition, laser treatment demonstrated a clear therapeutic effect in animal models of sporotrichosis, which can lead to PANoptosis-related apoptosis, pyroptosis, and necroptosis. Immune response-related macrophages perceive nucleic acid level changes through ZBP1 to recognize S. globosa and induce PANoptosis by activating the PANoptosome (RIPK1/RIPK3/FADD/CASP8) complex with a Th1/Th17 cell response to combat sporotrichosis.

Nd:YAG1064nm laser mediated PANoptosis resistance to sporotrichosis via ZBP1-PANoptosome-PANoptosis pathway.

## Linked entities

- **Genes:** ZBP1 (Z-DNA binding protein 1) [NCBI Gene 81030], RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737], RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035], FADD (Fas associated via death domain) [NCBI Gene 8772], CASP8 (caspase 8) [NCBI Gene 841], CASP1 (caspase 1) [NCBI Gene 834], GSDMD (gasdermin D) [NCBI Gene 79792], CASP3 (caspase 3) [NCBI Gene 836], MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259]
- **Proteins:** ZBP1 (Z-DNA binding protein 1), RIPK1 (receptor interacting serine/threonine kinase 1), RIPK3 (receptor interacting serine/threonine kinase 3), FADD (Fas associated via death domain), CASP8 (caspase 8), CASP1 (caspase 1), GSDMD (gasdermin D), CASP3 (caspase 3), MLKL (mixed lineage kinase domain like pseudokinase), IL17A (interleukin 17A), IFNG (interferon gamma)
- **Diseases:** sporotrichosis (MONDO:0005968)
- **Species:** Sporothrix globosa (taxon 545651)

## Full-text entities

- **Genes:** RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035] {aka RIP3}, RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737] {aka AIEFL, IMD57, RIP, RIP-1, RIP1}, ZBP1 (Z-DNA binding protein 1) [NCBI Gene 81030] {aka C20orf183, DAI, DLM-1, DLM1}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259] {aka hMLKL}, FADD (Fas associated via death domain) [NCBI Gene 8772] {aka GIG3, IMD90, MORT1}, CASP8 (caspase 8) [NCBI Gene 841] {aka ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5}
- **Diseases:** infected (MESH:D007239), S. globosa (MESH:D018455), skin lesions (MESH:D012871), Sporothrix globosa (MESH:D013174)
- **Chemicals:** calcium (MESH:D002118), Hoechst (-), PI (MESH:D010716)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Sporothrix globosa (species) [taxon 545651], Sphaerochaeta globosa (species) [taxon 1131703], Homo sapiens (human, species) [taxon 9606]

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11979269/full.md

---
Source: https://tomesphere.com/paper/PMC11979269